BARX1 and non-small cell lung carcinoma: To ascertain the clinical significance of BARX1 expression, we performed Kaplan–Meier survival analysis using GEPIA, and it showed that the high expression of BARX1 had a poor survival rate in prognosis analysis (Fig. 1I), indicating that BARX1 acts as an oncogene in NSCLC.